Literature DB >> 6163212

Specific antigen in serum of patients with colon carcinoma.

H Koprowski, M Herlyn, Z Steplewski, H F Sears.   

Abstract

The binding of monoclonal antibody specific for colon carcinoma was inhibited by serum from patients with adenocarcinoma of the colon but not by serum from patients with other bowel diseases or from healthy volunteers. Of other malignancies studied, serum from two patients with gastric carcinoma and two patients with pancreatic carcinoma also inhibited the specific binding of monoclonal antibody. The levels of carcinoembryonic antigen in these serum samples were not correlated with their levels of binding inhibition. Such monoclonal antibodies may prove useful for the detection of colorectal carcinoma.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6163212     DOI: 10.1126/science.6163212

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  131 in total

Review 1.  Protein biomarkers of ovarian cancer: the forest and the trees.

Authors:  Brian M Nolen; Anna E Lokshin
Journal:  Future Oncol       Date:  2012-01       Impact factor: 3.404

2.  Elevated baseline CA19-9 levels correlate with adverse prognosis in patients with early- or advanced-stage pancreas cancer.

Authors:  Ludmila Katherine Martin; Lai Wei; Elizabeth Trolli; Tanios Bekaii-Saab
Journal:  Med Oncol       Date:  2012-06-24       Impact factor: 3.064

3.  Implications of CA19-9 elevation for survival, staging, and treatment sequencing in intrahepatic cholangiocarcinoma: A national cohort analysis.

Authors:  John R Bergquist; Tommy Ivanics; Curtis B Storlie; Ryan T Groeschl; May C Tee; Elizabeth B Habermann; Rory L Smoot; Michael L Kendrick; Michael B Farnell; Lewis R Roberts; Gregory J Gores; David M Nagorney; Mark J Truty
Journal:  J Surg Oncol       Date:  2016-07-20       Impact factor: 3.454

4.  Extremely elevated CA19-9 in acute cholangitis.

Authors:  Shyr-Ming Sheen-Chen; Cheuk-Kwan Sun; Yei-Wei Liu; Hock-Liew Eng; Sheung-Fat Ko; Chung-Huang Kuo
Journal:  Dig Dis Sci       Date:  2007-04-03       Impact factor: 3.199

Review 5.  Current treatment options for pancreatic carcinoma.

Authors:  Emily Castellanos; Jordan Berlin; Dana Backlund Cardin
Journal:  Curr Oncol Rep       Date:  2011-06       Impact factor: 5.075

6.  Detection by monoclonal antibody of carbohydrate antigen CA 50 in serum of patients with carcinoma.

Authors:  J Holmgren; L Lindholm; B Persson; T Lagergård; O Nilsson; L Svennerholm; C M Rudenstam; B Unsgaard; F Yngvason; S Pettersson
Journal:  Br Med J (Clin Res Ed)       Date:  1984-05-19

7.  Diagnostic value of preoperative serum carcinoembryonic antigen and carbohydrate antigen 19-9 in colorectal cancer.

Authors:  E Polat; U Duman; M Duman; A E Atici; E Reyhan; T Dalgic; E B Bostanci; S Yol
Journal:  Curr Oncol       Date:  2014-02       Impact factor: 3.677

8.  False-positive findings for tumor markers after curative gastrectomy for gastric cancer.

Authors:  Takao Ohtsuka; Seiji Sato; Yoshihiko Kitajima; Masayuki Tanaka; Yuji Nakafusa; Kohji Miyazaki
Journal:  Dig Dis Sci       Date:  2007-05-03       Impact factor: 3.199

9.  An immunohistological study of breast cancer--with special reference to the expression of carbohydrate antigens and estrogen receptor status.

Authors:  M Sowa; Y S Chung; Y Kato; M Nishimura; T Kubo; H Maekawa; Y Fujimoto; K Umeyama; M Kawahara
Journal:  Jpn J Surg       Date:  1990-05

10.  Prognostic value of preoperative glucose to lymphocyte ratio in patients with resected pancreatic cancer.

Authors:  Yueming Zhang; Yaolin Xu; Dansong Wang; Tiantao Kuang; Wenchuan Wu; Xuefeng Xu; Dayong Jin; Wenhui Lou
Journal:  Int J Clin Oncol       Date:  2020-09-21       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.